Kabiven

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, the active ingredients in Kabiven, is an amino acid solution presented as a solution for injection for intravenous use. It provides essential and non‑essential amino acids to support protein synthesis and nitrogen balance in patients requiring parenteral nutrition.

GNH USA supplies Kabiven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kabiven is an amino acid solution used in parenteral nutrition to support protein synthesis and nitrogen balance. - Parenteral nutrition for patients unable to receive enteral feeding: provides a balanced amino acid profile to meet protein requirements. - Surgical or critically ill patients: supports protein synthesis and recovery during periods of catabolism. - Metabolic disorders requiring intravenous nutrition: supplies essential amino acids when oral intake is insufficient.

Kabiven may be associated with infusion‑related adverse reactions and metabolic disturbances.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels during infusion. - Electrolyte imbalance: changes in potassium, sodium or calcium concentrations. - Phlebitis: irritation or inflammation at the infusion site. - Nausea: mild gastrointestinal discomfort. - Fever: low‑grade temperature rise.

Serious or Rare Side Effects: - Metabolic acidosis: significant decrease in blood pH. - Hyperammonemia: elevated ammonia levels. - Anaphylactic reaction: severe allergic response requiring immediate treatment. - Hepatic dysfunction: abnormal liver enzyme elevations. - Renal impairment: worsening kidney function in susceptible patients.

When using Kabiven, clinicians should observe several safety considerations to minimize risks. - Patient assessment: evaluate renal and hepatic function before initiating therapy. - Electrolyte monitoring: check serum electrolytes regularly during infusion. - Blood glucose control: monitor glucose levels, especially in diabetic patients. - Fluid balance: adjust infusion rate to avoid fluid overload. - Compatibility: verify compatibility with other intravenous solutions and medications. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with certain intravenous drugs and metabolic conditions.

Major Interactions (Avoid): - High‑dose insulin: may exacerbate hypoglycemia when combined with amino acid infusion. - Calcium gluconate: can precipitate when mixed directly with the solution.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase electrolyte loss, requiring closer monitoring. - Parenteral lipid emulsions: concurrent administration can affect nitrogen balance. - Anticonvulsants (e.g., valproate): may alter plasma amino acid levels.